{
 "PrintNo":"S2383","Session":2025,"Chamber":"SENATE","BillType":"Senate","Published":"2025-01-16T16:14:59.308572Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2026-01-07","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2025-01-16","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2026-01-07","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1492,"Name":"Mario Mattera","Short":"MATTERA"}],
 "Title":"Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine",
 "Summary":"Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.",
 "LawSection":"Public Health Law",
 "LawCode":"Amd §3306, Pub Health L; amd §§220.00, 220.43, 220.41, 220.39, 220.21, 220.18, 220.16 & 220.09, Pen L",
 "ActClause":"AN ACT to amend the public health law, in relation to the classification of the drug xylazine as a controlled substance; and to amend the penal law, in relation to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine",
 "PreviousVersions":["S7753-2023"]
}